Redefining the Position of Hormonal Therapy in Endometrial Cancer in the Era of Molecular Classification-Reference-Cited by-同舟云学术

Redefining the Position of Hormonal Therapy in Endometrial Cancer in the Era of Molecular Classification

Published:2024-01-01 Issue:1 Volume:42 Page:8-12
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Pijnenborg Johanna M.A.¹²^ORCID,van Weelden Willem Jan¹³^ORCID,Reijnen Casper²⁴^ORCID,Xanthoulea Sofia⁵^ORCID,Romano Andrea⁵

Affiliation:

1. Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands

2. Radboud Institute of Health Science, Nijmegen, the Netherlands

3. Department of Obstetrics and Gynecology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands

4. Department of Radiation Oncology, University Medical Center, Nijmegen, the Netherlands

5. Department of Obstetrics and Gynecology, GROW-School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.00470

Reference51 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Integrated genomic characterization of endometrial carcinoma

3. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

4. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

5. The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asparaginase-like protein 1 as a prognostic tissue biomarker in clinicopathologically and molecularly characterized endometrial cancer;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. Bioengineering approaches for the endometrial research and application;Materials Today Bio;2024-06

3. Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma;Cancers;2024-05-30